United States law requires pharmaceutical companies to determine the appropriate length of time that a drug will meet ...

Software tasked with designing a type-II kinase inhibitor suggests 97 candidates in 10 minutes, three of which were both ...

The European Medicines Agency (EMA) has recommended market approval for Alzheimer’s antibody Leqembi (lecanemab), reversing ...